These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 33846501)

  • 21. A new device-aided cognitive function test, User eXperience-Trail Making Test (UX-TMT), sensitively detects neuropsychological performance in patients with dementia and Parkinson's disease.
    Kokubo N; Yokoi Y; Saitoh Y; Murata M; Maruo K; Takebayashi Y; Shinmei I; Yoshimoto S; Horikoshi M
    BMC Psychiatry; 2018 Jul; 18(1):220. PubMed ID: 29976167
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Danish version of the Oxford cognitive screen: a stroke-specific screening test as an alternative to the MoCA.
    Robotham RJ; Riis JO; Demeyere N
    Neuropsychol Dev Cogn B Aging Neuropsychol Cogn; 2020 Jan; 27(1):52-65. PubMed ID: 30741100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Using the Oxford Cognitive Screen to Detect Cognitive Impairment in Stroke Patients: A Comparison with the Mini-Mental State Examination.
    Mancuso M; Demeyere N; Abbruzzese L; Damora A; Varalta V; Pirrotta F; Antonucci G; Matano A; Caputo M; Caruso MG; Pontiggia GT; Coccia M; Ciancarelli I; Zoccolotti P;
    Front Neurol; 2018; 9():101. PubMed ID: 29541055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Measuring executive dysfunction in Parkinson's disease: Reliability and validity of the Spanish version of Frontal Assessment Battery (FAB-E).
    Hurtado-Pomares M; Terol-Cantero MC; Sánchez-Pérez A; Leiva-Santana C; Peral-Gómez P; Valera-Gran D; Navarrete-Muñoz EM
    PLoS One; 2018; 13(11):e0207698. PubMed ID: 30452476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stability, reliability, and validity of the THINC-it screening tool for cognitive impairment in depression: A psychometric exploration in healthy volunteers.
    Harrison JE; Barry H; Baune BT; Best MW; Bowie CR; Cha DS; Culpepper L; Fossati P; Greer TL; Harmer C; Klag E; Lam RW; Lee Y; Mansur RB; Wittchen HU; McIntyre RS
    Int J Methods Psychiatr Res; 2018 Sep; 27(3):e1736. PubMed ID: 30088298
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The validity of the Brain Injury Cognitive Screen (BICS) as a neuropsychological screening assessment for traumatic and non-traumatic brain injury.
    Vaughan FL; Neal JA; Mulla FN; Edwards B; Coetzer R
    Clin Neuropsychol; 2017 Apr; 31(3):544-568. PubMed ID: 27871218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Construct validity of the Visual Cognitive Assessment Test (VCAT)-a cross-cultural language-neutral cognitive screening tool.
    Low A; Lim L; Lim L; Wong B; Silva E; Ng KP; Kandiah N
    Int Psychogeriatr; 2020 Jan; 32(1):141-149. PubMed ID: 31111797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preliminary validation study of the Russian Birmingham Cognitive Screen.
    Kuzmina E; Humphreys GW; Riddoch MJ; Skvortsov AA; Weekes BS
    J Clin Exp Neuropsychol; 2018 Feb; 40(1):1-16. PubMed ID: 28290234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cultural and linguistic adaptation of the Oxford Cognitive Screen to the Spanish population.
    García-Manzanares MD; Sánchez-Pérez A; Alfaro-Sáez A; Limiñana-Gras RM; Sunyer-Catllà M; López-Roig S
    Neurologia (Engl Ed); 2022; 37(9):748-756. PubMed ID: 34649818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Criterion and convergent validity of the Montreal cognitive assessment with screening and standardized neuropsychological testing.
    Lam B; Middleton LE; Masellis M; Stuss DT; Harry RD; Kiss A; Black SE
    J Am Geriatr Soc; 2013 Dec; 61(12):2181-2185. PubMed ID: 24320735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Domain-specific versus generalized cognitive screening in acute stroke.
    Demeyere N; Riddoch MJ; Slavkova ED; Jones K; Reckless I; Mathieson P; Humphreys GW
    J Neurol; 2016 Feb; 263(2):306-315. PubMed ID: 26588918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The RAPID-II Neuropsychological Test battery for subjects aged 20 to 49 years: Norms and cognitive profile.
    Binetruy M; Mauny F; Lavaux M; Meyer A; Sylvestre G; Puyraveau M; Berger E; Magnin E; Vandel P; Galmiche J; Chopard G;
    Rev Neurol (Paris); 2018; 174(1-2):44-55. PubMed ID: 28673660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Oxford cognitive screen (OCS) as an acute predictor of long-term functional outcome in a prospective sample of stroke patients.
    Bisogno AL; Franco Novelletto L; Zangrossi A; De Pellegrin S; Facchini S; Basile AM; Baracchini C; Corbetta M
    Cortex; 2023 Sep; 166():33-42. PubMed ID: 37295236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Measuring impairments in memory and executive function in older people using the Revised Cambridge Cognitive Examination.
    Kessels RP; Mimpen G; Melis R; Rikkert MG
    Am J Geriatr Psychiatry; 2009 Sep; 17(9):793-801. PubMed ID: 19700951
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and Standardization of a New Cognitive Assessment Test Battery for Chinese Aphasic Patients: A Preliminary Study.
    Wu JB; Lyu ZH; Liu XJ; Li HP; Wang Q
    Chin Med J (Engl); 2017 Oct; 130(19):2283-2290. PubMed ID: 28937032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The night out task and scoring application: an ill-structured, open-ended clinic-based test representing cognitive capacities used in everyday situations.
    Schmitter-Edgecombe M; Cunningham R; McAlister C; Arrotta K; Weakley A
    Arch Clin Neuropsychol; 2021 May; 36(4):537-553. PubMed ID: 33089318
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of Instrumental Activities of Daily Living in Older Adults with Subjective Cognitive Decline Using the Virtual Reality Functional Capacity Assessment Tool (VRFCAT).
    Atkins AS; Khan A; Ulshen D; Vaughan A; Balentin D; Dickerson H; Liharska LE; Plassman B; Welsh-Bohmer K; Keefe RSE
    J Prev Alzheimers Dis; 2018; 5(4):216-234. PubMed ID: 30298179
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Toronto Cognitive Assessment (TorCA): normative data and validation to detect amnestic mild cognitive impairment.
    Freedman M; Leach L; Carmela Tartaglia M; Stokes KA; Goldberg Y; Spring R; Nourhaghighi N; Gee T; Strother SC; Alhaj MO; Borrie M; Darvesh S; Fernandez A; Fischer CE; Fogarty J; Greenberg BD; Gyenes M; Herrmann N; Keren R; Kirstein J; Kumar S; Lam B; Lena S; McAndrews MP; Naglie G; Partridge R; Rajji TK; Reichmann W; Uri Wolf M; Verhoeff NPLG; Waserman JL; Black SE; Tang-Wai DF
    Alzheimers Res Ther; 2018 Jul; 10(1):65. PubMed ID: 30021658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and Clinical Validity of a Mild Vascular Cognitive Impairment Assessment Tool for Korean Stroke Patients.
    Oh HS; Kim JS; Shim EB; Seo WS
    Asian Nurs Res (Korean Soc Nurs Sci); 2015 Sep; 9(3):226-34. PubMed ID: 26412627
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation and Normative Data for the Modified Telephone Interview for Cognitive Status: The Sydney Memory and Ageing Study.
    Bentvelzen AC; Crawford JD; Theobald A; Maston K; Slavin MJ; Reppermund S; Kang K; Numbers K; Brodaty H; Sachdev P; Kochan NA
    J Am Geriatr Soc; 2019 Oct; 67(10):2108-2115. PubMed ID: 31290146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.